VexoHeal

Veterinary Medical Device

Targeted exosome solution
that locates inflammation sites in companion animals

VexoHeal

Targeted exosome solution

Stem cell exosome-based veterinary medical device

Physically protects damaged skin from external factors and directly delivers the regenerative energy of stem cell exosomes through a pet-specific adhesive transparent wound dressing.

Exclusive supply from Yuhan Corporation (domestic) and License Medical (international)
Targeted exosome solution

The Scientific Evidence

75%

Higher cell proliferation rate

Promotes cell growth to induce rapid skin tissue regeneration

5x

Powerful anti-inflammatory effects

Reduces nitric oxide levels and decreases inflammatory gene expression

5x

Excellent absorption efficiency

High skin penetration ensures rapid treatment effects

Competitive Edge

Drug-Free Treatment

Drug-Free Treatment

Minimizes side effects of steroids and antibiotics, safe for repeated treatments.

Stress-Free Care

Stress-Free Care

Provides a comfortable skin recovery solution without repetitive dosing and injection pain.

Comparison items Existing treatments (such as steroids) VexoHeal
Effectiveness Focus on short-term effects, high recurrence potential High response rate for intractable skin diseases, promotes cell regeneration and strengthens barriers
Side effects Possible thinning of the skin, immune suppression, increased risk of infection No side effects (natural occurring substances), inflammation suppression through immune response regulation
Long-term
management
Increased tolerance and reduced effectiveness with long-term use Reduced recurrence rate and preventive effects, fundamentally strengthening the skin barrier
Cost Approximately 100,000 to 1,000,000 KRW per treatment Approximately 100,000 KRW per treatment

Global Expansion

Global Expansion Map
RECENS MEDICAL
International distribution
STEMEXONE
Medical device production
유한양행
Domestic distribution

Securing domestic and international distribution networks

Completed a 5-year exclusive supply contract with Yuhan Corporation and License Medical